BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24844281)

  • 61. Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis.
    Teng YD; Benn SC; Kalkanis SN; Shefner JM; Onario RC; Cheng B; Lachyankar MB; Marconi M; Li J; Yu D; Han I; Maragakis NJ; Lládo J; Erkmen K; Redmond DE; Sidman RL; Przedborski S; Rothstein JD; Brown RH; Snyder EY
    Sci Transl Med; 2012 Dec; 4(165):165ra164. PubMed ID: 23253611
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
    Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
    J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
    [TBL] [Abstract][Full Text] [Related]  

  • 64. hNT neurons delay onset of motor deficits in a model of amyotrophic lateral sclerosis.
    Willing AE; Garbuzova-Davis S; Saporta S; Milliken M; Cahill DW; Sanberg PR
    Brain Res Bull; 2001 Dec; 56(6):525-30. PubMed ID: 11786237
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis.
    Chang Q; Martin LJ
    J Neurosci; 2011 Feb; 31(8):2815-27. PubMed ID: 21414903
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
    Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
    Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
    Knippenberg S; Rath KJ; Böselt S; Thau-Habermann N; Schwarz SC; Dengler R; Wegner F; Petri S
    J Tissue Eng Regen Med; 2017 Mar; 11(3):751-764. PubMed ID: 25641599
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dysregulation of Rac or Rho elicits death of motor neurons and activation of these GTPases is altered in the G93A mutant hSOD1 mouse model of amyotrophic lateral sclerosis.
    Stankiewicz TR; Pena C; Bouchard RJ; Linseman DA
    Neurobiol Dis; 2020 Mar; 136():104743. PubMed ID: 31931138
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Generation and optimization of highly pure motor neurons from human induced pluripotent stem cells via lentiviral delivery of transcription factors.
    Sepehrimanesh M; Ding B
    Am J Physiol Cell Physiol; 2020 Oct; 319(4):C771-C780. PubMed ID: 32783653
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G⁹³A transgenic ALS mice.
    Ozdinler PH; Benn S; Yamamoto TH; Güzel M; Brown RH; Macklis JD
    J Neurosci; 2011 Mar; 31(11):4166-77. PubMed ID: 21411657
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis.
    Schütz B
    Neurobiol Dis; 2005 Oct; 20(1):131-40. PubMed ID: 16137574
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
    Knippenberg S; Thau N; Schwabe K; Dengler R; Schambach A; Hass R; Petri S
    Neurodegener Dis; 2012; 9(3):107-20. PubMed ID: 22122965
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury.
    Lepore AC
    J Vis Exp; 2011 Sep; (55):. PubMed ID: 21946609
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis.
    Hemendinger R; Wang J; Malik S; Persinski R; Copeland J; Emerich D; Gores P; Halberstadt C; Rosenfeld J
    Exp Neurol; 2005 Dec; 196(2):235-43. PubMed ID: 16242126
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1
    Shang HY; Zhang JJ; Fu ZF; Liu YF; Li S; Chen S; Le WD
    CNS Neurosci Ther; 2020 Jan; 26(1):90-100. PubMed ID: 31318169
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo.
    Qian K; Huang H; Peterson A; Hu B; Maragakis NJ; Ming GL; Chen H; Zhang SC
    Stem Cell Reports; 2017 Apr; 8(4):843-855. PubMed ID: 28366455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protein-bound crotonaldehyde accumulates in the spinal cord of superoxide dismutase-1 mutation-associated familial amyotrophic lateral sclerosis and its transgenic mouse model.
    Shibata N; Kawaguchi M; Uchida K; Kakita A; Takahashi H; Nakano R; Fujimura H; Sakoda S; Ihara Y; Nobukuni K; Takehisa Y; Kuroda S; Kokubo Y; Kuzuhara S; Honma T; Mochizuki Y; Mizutani T; Yamada S; Toi S; Sasaki S; Iwata M; Hirano A; Yamamoto T; Kato Y; Sawada T; Kobayashi M
    Neuropathology; 2007 Feb; 27(1):49-61. PubMed ID: 17319283
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.
    Thonhoff JR; Ojeda L; Wu P
    Curr Stem Cell Res Ther; 2009 Sep; 4(3):178-99. PubMed ID: 19492980
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Hayes A; Bellantuono I; Aebischer P; Svendsen CN
    Mol Ther; 2008 Dec; 16(12):2002-10. PubMed ID: 18797452
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
    Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
    Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.